T. Yamashita

发表

Novel protein engineering strategy for creating highly receptor-selective mutant TNFs.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2009, Biochemical and biophysical research communications.

Limited expression of reticulocalbin-1 in lymphatic endothelial cells in lung tumor but not in normal lung.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2011, Biochemical and biophysical research communications.

Urban aerosols induce pro-inflammatory cytokine production in macrophages and cause airway inflammation in vivo.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2010, Biological & pharmaceutical bulletin.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2011, Biomaterials.

[Development of anti-tumor blood vessel antibodies by phage display method].

Y. Tsutsumi, K. Maruyama, K. Nagano, 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Eph receptor A10 has a potential as a target for a prostate cancer therapy.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Biochemical and biophysical research communications.

Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2010, Die Pharmazie.

Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2012, Biochemical and biophysical research communications.

Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Die Pharmazie.

Arsenic trioxide inhibits human t cell-lymphotropic virus-1-induced syncytiums by down-regulating gp46.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2009, Biological & pharmaceutical bulletin.

Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2011, Biomaterials.

Effect of amorphous silica nanoparticles on in vitro RANKL-induced osteoclast differentiation in murine macrophages

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2011, Nanoscale research letters.

Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2011, Biomaterials.

Carbon Nanotubes Elicit DNA Damage and Inflammatory Response Relative to Their Size and Shape

Yasuo Yoshioka, Yasuo Tsutsumi, Haruhiko Kamada, 2010, Inflammation.

Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2012, Nanotechnology.

Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells.

Y. Yoshioka, Y. Tsutsumi, T. Imazawa, 2010, Die Pharmazie.

Identification and evaluation of metastasis-related proteins, oxysterol binding protein-like 5 and calumenin, in lung tumors.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2015, International journal of oncology.

Ephrin type-A receptor 2 on tumor-derived exosomes enhances angiogenesis through the activation of MAPK signaling.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2019, Die Pharmazie.

Carbon Nanomaterials: Efficacy and Safety for Nanomedicine

Y. Yoshioka, Y. Tsutsumi, T. Yoshikawa, 2012, Materials.

Size-dependent immune-modulating effect of amorphous nanosilica particles.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2011, Die Pharmazie.

Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2013, Cancer medicine.

Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2012, Pharmazie.

Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis

Y. Tsutsumi, H. Kamada, H. Mori, 2013, Neuroscience Letters.

Effect of amorphous silica nanoparticles on in vitro RANKL-induced osteoclast differentiation in murine macrophages

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2011, Nanoscale research letters.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Y. Yoshioka, Y. Tsutsumi, H. Kamada, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Identification and evaluation of metastasis-related proteins, oxysterol binding protein-like 5 and calumenin, in lung tumors.

Y. Yoshioka, Y. Tsutsumi, S. Nakagawa, 2015, International journal of oncology.